Roswell secures $15.4 million in new funding Research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million. These competitive awards from both government agencies and private funders will fuel research to overcome obstacles in treating diseases like prostate, breast, colon and lung cancer, as well as less-common cancers like multiple myeloma and esophageal cancer. They include the first National Institutes of Health funding to study a new electronic tobacco device, plus new state funds from Empire State Development supporting Roswell Park’s role in the National Cancer Institute’s Cancer Moonshot initiative.

“The announcement today of more than $15 million in grants and awards to Roswell Park, including from the National Cancer Institute and National Institutes of Health, will help the cancer center continue the effort to make critical advancements in our understanding of the disease and develop new treatments to alleviate suffering and improve life quality,” said Congressman Brian Higgins.

“Roswell Park is at the forefront of cutting-edge medical research and, with New York state support for its role in the Cancer Moonshot effort, will fuel faster development and broader access to life-saving treatments that will prolong and save lives,” says Howard Zemsky, Empire State Development president, CEO and commissioner.